Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Numerous mutations/polymorphisms of the POR gene, encoding NADPH:cytochrome P450 oxidoreductase (CYPOR), have been described in patients with Antley-Bixler syndrome (ABS), presenting with craniofacial dysmorphogenesis, and/or disordered steroidogenesis, exhibiting ambiguous genitalia. CYPOR is the obligate electron donor to 51 microsomal cytochromes P450 that catalyze critical steroidogenic and xenobiotic reactions, and to two heme oxygenase isoforms, among other redox partners. To address the molecular basis of CYPOR dysfunction in ABS patients, the soluble catalytic domain of human CYPOR was bacterially expressed. WT enzyme was green, due to air-stable FMN semiquinone (blue) and oxidized FAD (yellow). The ABS mutant V492E was blue-gray. Flavin analysis indicated that WT had a protein:FAD:FMN ratio of approximately 1:1:1, whereas approximately 1:0.1:0.9 was observed for V492E, which retained 9% of the WT k(cat)/K(m) in NADPH:cytochrome c reductase assays. V492E was reconstituted upon addition of FAD, post-purification, as shown by flavin analysis, activity assay, and near UV-visible CD. Both Y459H and V492E were expressed as membrane anchor-containing proteins, which also exhibited FAD deficiency. CYP4A4-catalyzed omega-hydroxylation of prostaglandin E1 was supported by WT CYPOR but not by either of the ABS mutants. Hydroxylation activity was rescued for both Y459H and V492E upon addition of FAD to the reaction. Based on these findings, decreased FAD-binding affinity is proposed as the basis of the observed loss of CYPOR function in the Y459H and V492E POR mutations in ABS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Chemical and biological evolution of a nucleotide-binding protein
Rossmann, M. G., Moras, D., & Olsen, K. W. (1974) · Nature · doi:10.1038/250194a0 · Cited by 1,469
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Self-citationStructure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692
[92] The preparation and properties of microsomal TPNH-cytochrome c reductase from pig liver
Masters, B. S. S., Williams, C. H., & Kamin, H. (1967) · Methods in Enzymology · doi:10.1016/0076-6879(67)10098-0 · Cited by 554
Self-citationKarplus, P. A., Daniels, M. J., & Herriott, J. R. (1991) · Science · doi:10.1126/science.1986412 · Cited by 536
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Abnormality of a Thiamine-Requiring Enzyme in Patients with Wernicke-Korsakoff Syndrome
Blass, J. P., & Gibson, G. E. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712222972503 · Cited by 392
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Porter, T. D., & Kasper, C. B. (1986) · Biochemistry · doi:10.1021/bi00355a036 · Cited by 241
Shen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
NADPH-Cytochrome P450 Oxidoreductase
Hubbard, P. A., Shen, A. L., Paschke, R., Kasper, C. B., & Kim, J.-J. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101731200 · Cited by 216
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Black, S. D., & Coon, M. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83868-1 · Cited by 174
Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155
Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153
Oprian, D. D., & Coon, M. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34223-6 · Cited by 146
Determination of the Redox Properties of Human NADPH-Cytochrome P450 Reductase
Munro, A. W., Noble, M. A., Robledo, L., Daff, S. N., & Chapman, S. K. (2001) · Biochemistry · doi:10.1021/bi001718u · Cited by 139
Shen, A. L., & Kasper, C. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27475 · Cited by 136
Tollin, G., & Edmondson, D. E. (1971) · Biochemistry · doi:10.1021/bi00777a018 · Cited by 129
Black, S. D., French, J. S., Williams, C. H., & Coon, M. J. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91238-5 · Cited by 115
Adachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K., & Oka, A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30169 · Cited by 110
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome
Chun, K., Siegel-Bartelt, J., Chitayat, D., Phillips, J., & Ray, P. N. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980518)77:3<219::aid-ajmg6>3.0.co;2-k · Cited by 101
Treatment of complex I deficiency with riboflavin
Bernsen, P. L. J. A., Gabreëls, F. J. M., Ruitenbeek, W., & Hamburger, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90108-b · Cited by 98
Iyanagi, T. (1977) · Biochemistry · doi:10.1021/bi00631a021 · Cited by 91
Mitochondrial myopathy with tRNA Leu(UUR) mutation and complex I deficiency responsive to riboflavin
Ogle, R. F., Christodoulou, J., Fagan, E., Blok, R. B., Kirby, D. M., Seller, K. L., Dahl, H. M., & Thorburn, D. R. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70323-8 · Cited by 78
Vergani, L., Barile, M., Angelini, C., Burlina, A. B., Nijtmans, L., Freda, M. P., Brizio, C., Zerbetto, E., & Dabbeni-Sala, F. (1999) · Brain · doi:10.1093/brain/122.12.2401 · Cited by 76
Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase.
Kurzban, G. P., & Strobel, H. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57476-2 · Cited by 69
Davydov, D. R., Kariakin, A. A., Petushkova, N. A., & Peterson, J. A. (2000) · Biochemistry · doi:10.1021/bi992936u · Cited by 58
Kurzban, G. P., Howarth, J., Palmer, G., & Strobel, H. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38341-3 · Cited by 33
Analysis of insulin preparations by reversed-phase high-performance liquid chromatography
Lloyd, L. F., & Corran, P. H. (1982) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)99623-7 · Cited by 33
Hydrolysis of riboflavin nucleotides in plasma monitored by high-performance liquid chromatography
Pietta, P., Calatroni, A., & Rava, A. (1982) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84288-7 · Cited by 32
Electron transfer flavoprotein
Bell, R. B., Brownell, A. K. W., Roe, C. R., Engel, A. G., Goodman, S. I., Frerman, F. E., Seccombe, D. W., & Snyder, F. F. (1990) · Neurology · doi:10.1212/wnl.40.11.1779 · Cited by 31
Engineering of proteolytically stable NADPH-cytochrome P450 reductase
Bonina, T. A., Gilep, A. A., Estabrook, R. W., & Usanov, S. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0122-3 · Cited by 30
Kondo, S., Sakaki, T., Ohkawa, H., & Inouye, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0455 · Cited by 30
Kmoch, S., Zeman, J., Hřebı́ček, M., Ryba, L., Kristensen, M., & Gregersen, N. V. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711774 · Cited by 24
Bewley, M. C., Davis, C. A., Marohnic, C. C., Taormina, D., & Barber, M. J. (2003) · Biochemistry · doi:10.1021/bi034915c · Cited by 17
Self-citationVitamin B 6 -Responsive and -Unresponsive Cystathioninuria: Two Variant Molecular Forms
Pascal, T. A., Gaull, G. E., Beratis, N. G., Gillam, B. M., Tallan, H. H., & Hirschhorn, K. (1975) · Science · doi:10.1126/science.1198108 · Cited by 17
Scholte, H. R., Busch, H. F. M., & Luyt‐Houwen, I. E. M. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02435969 · Cited by 16
Makovec, T., & Breskvar, K. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00145-0 · Cited by 14
Expressed CYP4A4 Metabolism of Prostaglandin E1 and Arachidonic Acid
Aitken, A. E., Roman, L. J., Loughran, P., de la Garza, M., & Masters, B. S. S. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2501 · Cited by 13
Self-citationPreparation and Characterization of a 5‘-DeazaFAD T491V NADPH−Cytochrome P450 Reductase
Zhang, H., Gruenke, L. D., Sarıbaş, A. S., Im, S., Shen, A. L., Kasper, C. B., & Waskell, L. A. (2003) · Biochemistry · doi:10.1021/bi030081m · Cited by 8
Kurzban, G. P., & Strobel, H. W. (1986) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)90344-9 · Cited by 5
Research works printed but not linked: 2
- Antley, 1975, Birth Defects Orig. Artic Ser., 11, 397
- Auchus, 1999, Mol. Endocrinol., 13, 1169
Cited by
Iyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
Metabolic host responses to infection by intracellular bacterial pathogens
Eisenreich, W., Heesemann, J., Rudel, T., & Goebel, W. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00024 · Cited by 217
Huang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy
Sibbing, D., Pfeufer, A., Perisic, T., Mannes, A. M., Fritz‐Wolf, K., Unwin, S., Sinner, M. F., Gieger, C., Gloeckner, C. J., Wichmann, H. ‐., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq507 · Cited by 120
Metadata
- Authors
- Marohnic, C. C., Panda, S. P., Martásek, P., & Masters, B. S.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Masters, Bettie Sue
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 47
- Pages
- 35975-35982
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1975722739
- Semantic Scholar
- 686128bde7d2b5a92b925b6d02f40828419fc902
- Cited by
- 57
- References
- 46
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 5 · 2012: 5
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5082 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL30050)
- University of Texas Health Science Center at San Antonio
- National Heart, Lung, and Blood Institute (HL30050)
- National Institute of General Medical Sciences (R01GM081568)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- Antley-Bixler syndrome, NADPH-cytochrome P450 reductase, POR gene, FAD binding, flavin cofactor, enzyme reconstitution, ambiguous genitalia, steroidogenesis
- MeSH terms
- Catalysis, Circular Dichroism, Cloning, Molecular, Craniosynostoses, Flavin-Adenine Dinucleotide, Flavins, Humans, Kinetics, Models, Molecular, Mutation, NADPH-Ferrihemoprotein Reductase, Oxidation-Reduction, Protein Binding, Syndrome, Mutagenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.